AROI-ESTRO GYN Teaching Course

Common dose planning aims for target structures

EBRT dose BT dose EQD2

Total EQD2 EBRT+BT

Elective lymph node target: CTV-E 45-50Gy

-

45-50Gy

Pathological lymph nodes

55-60Gy

0-4Gy

60Gy

Intermediate Risk CTV: CTV IR

45-50Gy

15-20Gy 60-70Gy

High Risk CTV: CTV HR

45-50Gy

35-45Gy 85-90Gy

GTV

45-50Gy

50-55Gy 95-100Gy

Point A

45-50Gy

30-40Gy 80-85Gy